You have 9 free searches left this month | for more free features.

Hematology parameter

Showing 1 - 25 of 2,177

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC

Completed
  • Sepsis
  • +3 more
  • Diagnostic Test: CBC-DIFF Monocyte Volume Width Distribution (MDW)
  • Hackensack, New Jersey
    Hackensack University Medical Center
Jul 15, 2022

Simple Endpoint Study - Indiana University Hospital

Completed
  • Sepsis
  • +3 more
  • CBC-DIFF Monocyte Volume Width Distribution (MDW)
  • Indianapolis, Indiana
    Indiana University Methodist Hospital
Jul 15, 2022

COVID-19 Trial in Makassar (Vitamin D3 10000 IU, Vitamin D3 1000 IU)

Completed
  • COVID-19
  • Vitamin D3 10000 IU
  • Vitamin D3 1000 IU
  • Makassar, South Sulawesi, Indonesia
    Wahidin Sudirohusodo General Hospital
Nov 17, 2021

Potential Reduction of Time to Antibiotics - Washington

Completed
  • Sepsis
  • +3 more
  • CBC-DIFF Monocyte Volume Width Distribution (MDW)
  • Saint Louis, Missouri
    Washington University
Mar 15, 2021

Potential Reduction of Time to Antibiotics - Baylor S&W

Completed
  • Sepsis
  • +3 more
  • CBC-DIFF Monocyte Volume Width Distribution (MDW)
  • Temple, Texas
    Baylor Scott & White MEdical Center
Jan 26, 2021

Multimodal MR Imaging in Cognitive Assessment of Moderate

Recruiting
  • Brain Injuries
  • Glasgow coma scale
  • Xi'an, Shaanxi, China
    The First Affiliated Hospital of Xi'an Jiaotong University
Oct 19, 2023

HIV Trial (Cabotegravir IR Formulation (reference), Cabotegravir DT Formulation (test 1), Cabotegravir DT Formulation (test 2))

Not yet recruiting
  • HIV Infections
  • Cabotegravir IR Formulation (reference)
  • +2 more
  • (no location specified)
Mar 8, 2023

Asthma Trial (Salbutamol HFA-152a, Salbutamol HFA-134a)

Not yet recruiting
  • Asthma
  • Salbutamol HFA-152a
  • Salbutamol HFA-134a
  • (no location specified)
Mar 17, 2023

Smallpox Trial in Overland Park (Brincidofovir)

Recruiting
  • Smallpox
  • Overland Park, Kansas
    Altasciences
Jul 5, 2023

HIV Trial in Las Vegas (Cabotegravir 200 mg/mL, Cabotegravir 400 mg/mL, Recombinant human hyaluronidase PH20 (rHuPH20))

Recruiting
  • HIV Infections
  • Cabotegravir 200 mg/mL
  • +2 more
  • Orlando, Florida
  • +3 more
Dec 1, 2022

Atopic Dermatitis Trial in Hamburg, Magdeburg, Wuppertal (si-544, Placebo)

Recruiting
  • Atopic Dermatitis
  • Hamburg, Germany
  • +3 more
Sep 27, 2022

HIV Trial in Canada, United States (CAB LA, RPV LA, RPV)

Active, not recruiting
  • HIV Infections
  • CAB LA
  • +3 more
  • Phoenix, Arizona
  • +29 more
Jan 22, 2023

Urinary Tract Infections Trial (Gepotidacin, Nitrofurantoin, Placebo)

Not yet recruiting
  • Urinary Tract Infections
  • (no location specified)
Dec 9, 2022

Pain Trial in Herston, Melbourne (GSK3858279, Placebo)

Recruiting
  • Pain
  • Herston, Queensland, Australia
  • +1 more
Jun 13, 2022

Essential Tremor Trial in Bingham Farms, Raleigh (SAGE-547, Placebo)

Completed
  • Essential Tremor
  • Bingham Farms, Michigan
  • +1 more
Jun 3, 2022

Arthritis, Rheumatoid Trial (Otilimab)

Not yet recruiting
  • Arthritis, Rheumatoid
  • Otilimab
  • (no location specified)
Mar 22, 2022

Urinary Tract Infections Trial in Worldwide (Gepotidacin, Placebo matching nitrofurantoin, Nitrofurantoin)

Completed
  • Urinary Tract Infections
  • Birmingham, Alabama
  • +103 more
Dec 14, 2022

Human Immunodeficiency Virus Type 1 (HIV-1) Trial in Worldwide (Cabotegravir - Injectable Suspension (CAB LA), Rilpivirine -

Active, not recruiting
  • Human Immunodeficiency Virus Type 1 (HIV-1)
  • Cabotegravir - Injectable Suspension (CAB LA)
  • Rilpivirine - Injectable Suspension (RPV LA)
  • Macon, Georgia
  • +29 more
May 31, 2023

Urinary Tract Infections Trial in Worldwide (Gepotidacin, Placebo matching nitrofurantoin, Nitrofurantoin)

Completed
  • Urinary Tract Infections
  • Birmingham, Alabama
  • +112 more
Dec 15, 2022

Solid Tumor, Adult Trial in United States (SM08502)

Active, not recruiting
  • Solid Tumor, Adult
  • Scottsdale, Arizona
  • +18 more
Oct 17, 2022

Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (GSK744, GSK744 LA, TMC278 LA)

Active, not recruiting
  • Infection, Human Immunodeficiency Virus
  • HIV Infections
  • Birmingham, Alabama
  • +49 more
Dec 26, 2022

T-Cell Lymphoma Trial (Brentuximab vedotin)

Not yet recruiting
  • T-Cell Lymphoma
  • Brentuximab vedotin
  • (no location specified)
Jun 30, 2022

Multiple Myeloma Trial in Beijing, Jiang Su Province (Belantamab mafodotin)

Completed
  • Multiple Myeloma
  • Belantamab mafodotin
  • Beijing, China
  • +2 more
Feb 8, 2022

Lymphocyte Count and High Fluorescent Count Correlate With Liver

Recruiting
  • Dengue Fever
  • Blood and Liver Function test
  • Sukoharjo, Central Java, Indonesia
  • +1 more
Jun 1, 2022